BioXcel Therapeutics Inc (BTAI) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BTAI revenue for 2026-06-30 was $388.0K. Net income was -$27.4M. Revenue was up 88.3% from 2026-03-31 to 2026-06-30. BTAI currently screens at market cap $36.1M.
Use this BTAI page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the BTAI quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the BTAI SEC filings page. Lician reads the product cache first so this HTML stays unique to BioXcel Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full BTAI income, balance, and cash tables.